Articles From: Synthetic Biologics on Track to Initiate Clinical Program for SYN-004 to Protect Against C. difficile to Sysorex Global Holdings Corp. Second Quarter 2014 Financial Results and Company Update Conference Call on Thursday, August 14, 2014


2014/8/5
-- Executed Agreement with Evonik for Formulation Development, Analytical Services andClinical Drug Manufacturing -- --
Sign-up for Synthetic Biologics on Track to Initiate Clinical Program for SYN-004 to Protect Against C. difficile investment picks
2014/8/14
-- Expanded Data from Phase II MS Trial to be Released Next Month; Plans on Course to Advance C.
Sign-up for Synthetic Biologics Reports Second Quarter 2014 Financial Results and Operational Highlights investment picks
2014/6/25
-- Company's License Covers C-IBS, Type 2 Diabetes and Obesity --
Sign-up for Synthetic Biologics Reports that Licensor Cedars-Sinai Finds Eradication of Gut Methane Improves Insulin Sensitivity and Lipid Profiles in Study of Pre-Diabetic, Obese Patients investment picks
-- Keynote Speaker: Mark Pimentel, M.D., FRCP(C), Director, GI Motility Program and Laboratory, Cedars-Sinai Medical Center; Chairman, Synthetic Biologics' C-IBS Clinical Advisory Board --
Sign-up for Synthetic Biologics to Host Irritable Bowel Syndrome (IBS) Investor Day investment picks
-- Company Completes Final Preclinical Toxicology Study and Prepares to File Investigational New Drug (IND) in 2H 2014 --
Sign-up for Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections investment picks
2014/8/7
-- Conference Call Scheduled for Thursday, August 14, 2014, at 8:30 am EDT --
Sign-up for Synthetic Biologics to Report Second Quarter 2014 Financial Results investment picks
-- Keynote Speaker: Mark Pimentel, M.D., FRCP(C), Director, GI Motility Program and Laboratory, Cedars-Sinai Medical Center; Chairman, Synthetic Biologics' C-IBS Clinical Advisory Board --
Sign-up for Synthetic Biologics to Webcast September 16, 2014 Irritable Bowel Syndrome (IBS) Investor Day investment picks
2014/7/29
ROCKVILLE, Md.
Sign-up for Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity investment picks
2014/7/21
Company's License from The University of Texas at Austin Covers Development of SYN-005 in Collaboration with Intrexon Corporation ROCKVILLE, Md.
Sign-up for Synthetic Biologics' Academic Collaborator to Present Novel Monoclonal Antibody Combination for Treating Whooping Cough (Pertussis) at Gordon Research Conference investment picks
-- SYN-005 Program Targeting Pertussis Toxin to be Highlighted in Oral Presentation --
Sign-up for Synthetic Biologics' Academic Collaborator to Present Novel Monoclonal Antibody Combination for Treatment of Whooping Cough (Pertussis) at 54th ICAAC investment picks
~ 1Q15 Sales Increase 4.6%~ ~Formula Sales Increase 20.8% ~~ Reiterates FY15 Guidance Forecast QINGDAO, China and ROCKVILLE, Md.
Sign-up for Synutra Reports First Quarter Fiscal 2015 Financial Results investment picks
~ 4Q14 Sales Increase 36% YoY while 4Q14 Net Income Increases 195% YoY ~~ Reiterates FY15 Sales and Earnings Guidance Forecast QINGDAO, China and ROCKVILLE, Md.
Sign-up for Synutra Reports Fourth Quarter and Full Year of Fiscal 2014 Financial Results investment picks
QINGDAO, China and ROCKVILLE, Md.
Sign-up for Synutra to Announce First Quarter Fiscal 2015 Financial Results investment picks
2014/7/31
Sypris Solutions, Inc. (Nasdaq/NM: SYPR) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.02 (two cents) per share on July 29, 2014.
Sign-up for Sypris Declares Regular Quarterly Cash Dividend of $0.02 Per Share investment picks
2014/8/5
Sypris Solutions, Inc. (Nasdaq/NM: SYPR) today reported financial results for its second quarter ended June 29, 2014.
Sign-up for Sypris Reports Second Quarter Results investment picks
2014/7/22
Sypris Solutions, Inc. (NASDAQ/NM:SYPR) will provide an online, real-time webcast and rebroadcast of its conference call for the second quarter 2014 financial results on Tuesday, August 5, 2014.
Sign-up for Sypris Solutions, Inc. to Announce Second Quarter Financial Results, Host Conference Call and Webcast on August 5 investment picks
2014/9/9
SUVA, Fiji--Fiji's military chief said Wednesday that Syrian insurgents have agreed to release 45 United Nations peacekeepers later this week without conditions.
Sign-up for Syrian Militants to Release Peacekeepers investment picks
HOUSTON, Aug.
Sign-up for Sysco Declares Quarterly Dividend Payment investment picks
HOUSTON, July 17, 2014 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) has agreed to settle with the State of California all claims related to its past use of drop sites in the state.
Sign-up for Sysco Settles California Investigations, Reiterates Its Commitment to Food Safety investment picks
HOUSTON, July 28, 2014 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) announced today that it will webcast its fourth quarter and fiscal 2014 earnings conference call at 10 a.m. (Eastern), Monday, August 11.
Sign-up for Sysco to Webcast Fourth Quarter and Fiscal 2014 Earnings Conference Call investment picks
HOUSTON, June 16, 2014 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) issued the following statement in response to a recent report containing unfounded, inaccurate and irresponsible rumors regarding the status of the Federal Trade Commission's review of the proposed Sysco-US Foods merger.
Sign-up for Sysco-US Foods Merger Regulatory Review Remains on Track investment picks
Two Sysorex Global Holdings Corp.
Sign-up for Sysorex Companies Open Joint Offices and Technology Demonstration Center in Southern California investment picks
Sysorex Global Holdings Corp.
Sign-up for Sysorex Global Holdings Corp. Announces Results for the Quarter Ended June 30, 2014 investment picks
Sysorex Global Holdings Corp.
Sign-up for Sysorex Global Holdings Corp. Appoints New Directors investment picks
Sysorex Global Holdings Corp.
Sign-up for Sysorex Global Holdings Corp. Names Craig Harper CTO investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Synthetic Biologics on Track to Initiate Clinical Program for SYN-004 to Protect Against C. difficile to Sysorex Global Holdings Corp. Second Quarter 2014 Financial Results and Company Update Conference Call on Thursday, August 14, 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices